How Japanese science is trying to reassert its research strength (original) (raw)

Successes in life sciences and international collaboration could be key to boosting the country’s high-quality output.

By

  1. Tim Hornyak
    1. Tim Hornyak is a freelance science and technology journalist in Tokyo.

After five years studying genome editing at Harvard Medical School in Boston, Massachusetts, Keiji Nishida returned to Japan in 2013, and soon felt worried. How would his home country compete in this new field? It was a time when the gene-editing technique, CRISPR–Cas9, was making headlines for its groundbreaking potential to cheaply splice and rearrange genes, raising hopes for cures for many diseases.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 52 print issues and online access

$199.00 per year

only $3.83 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Nature 615, S48-S51 (2023)

doi: https://doi.org/10.1038/d41586-023-00657-2

This article is part of Nature Index 2023 Japan, an editorially independent supplement. Advertisers have no influence over the content.

Updates & Corrections

References

  1. Nishida, K. et al. Science 353, aaf8729 (2016).
    Article PubMed Google Scholar
  2. Nakaya, T. et al. Nature Commun. 13, 7575 (2022).
    Article PubMed Google Scholar
  3. van Dyck, C. H. et al. N. Engl. J. Med. 388, 9–21 (2023).
    Article PubMed Google Scholar
  4. O’Donnell, M. A. J. Cell. Biol. 218, 3529–3530 (2019).
    Article PubMed Google Scholar

Download references

Subjects

Latest on: